Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Bessemer Venture Partners (BVP) is a venture capital firm that provides investment management solutions. The firm offers healthcare and related technology and services.it also provides investment in banking; and software, platform and infrastructures as a service. BVP ventures in the areas of cleantech, cloud computing, cyber security, financial services, healthcare, infrastructure, mobile and online retail, among others. It caters B2D, cloud and SaaS, mobile, data center, infrastructure, networking, security, Space technology and storage. The company has its presence in the US, India, and Israel. BVP is headquartered in Larchmont, New York, the US. Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. 3
- Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH143676D Number of Pages : 64 Report Format : PDF Publisher Information : 4
5
Table Of Contents for Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Bessemer Venture Partners, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Bessemer Venture Partners, Medical Devices Deals, 2010 to YTD 2016 10Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deal Details 16Venture Financing 16Allena Pharma Raises USD25 Million in Series B Venture Financing 16Flex Pharma Raises USD40 Million in Venture Financing 18NephroPlus Raises USD10 Million in Series B Financing 20Proteon Therapeutics Raises USD45 Million in Series D Financing 21Alcresta Raises US$10 Million In Series B Financing 24Health Essentials Raises US$51 Million In Venture Financing 26Alcresta Raises US$10 Million In Series A Financing 28OvaScience Raises US$37 Million In Series B Financing 30Atopix Raises USD5.7 Million in Series A Financing Round 32NephroPlus Raises USD4 Million in Venture Financing 34Cerulean Pharma Secures US$15 Million In Series D Financing 35NephroPlus Raises US$37 Million In Venture Financing 37Allena Pharma Secures US$15 Million In Series A Financing 38Proteon Therapeutics Secures US$15.2 Million In Venture Financing 39OvaScience Secures US$6 Million In Series A Financing 41Verastem Secures US$32 Million In Series B Financing 42Verastem Secures US$16 Million In Series A Round Of Financing 44Cerulean Pharma Secures US$24 Million In Series C Financing 46Oxagen Raises US$33 Million In Series C Financing 48Alnara Pharma Raises US$35 Million In Series B Financing 51Acquisition 53Biogen Idec Completes Acquisition Of Remaining Stake In Stromedix, Provider Of Therapies For Fibrosis 53Insmed Acquires Transave 56Eli Lilly Acquires Alnara Pharma 59Bessemer Venture Partners - Key Competitors 61Key Employees 62Locations And Subsidiaries 63Head Office 63Other Locations & Subsidiaries 63Appendix 64Methodology 64About GlobalData 64Contact Us 64Disclaimer 64 6
List Of Tables in Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Bessemer Venture Partners, Pharmaceuticals & Healthcare, Key Facts 1 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Bessemer Venture Partners, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Bessemer Venture Partners, Deals By Therapy Area, 2010 to YTD 2016 8 Bessemer Venture Partners, Medical Devices Deals, 2010 to YTD 2016 10 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11 Allena Pharma Raises USD25 Million in Series B Venture Financing 16 Flex Pharma Raises USD40 Million in Venture Financing 18 NephroPlus Raises USD10 Million in Series B Financing 20 Proteon Therapeutics Raises USD45 Million in Series D Financing 21 Alcresta Raises US$10 Million In Series B Financing 24 Health Essentials Raises US$51 Million In Venture Financing 26 Alcresta Raises US$10 Million In Series A Financing 28 OvaScience Raises US$37 Million In Series B Financing 30 Atopix Raises USD5.7 Million in Series A Financing Round 32 NephroPlus Raises USD4 Million in Venture Financing 34 Cerulean Pharma Secures US$15 Million In Series D Financing 35 NephroPlus Raises US$37 Million In Venture Financing 37 Allena Pharma Secures US$15 Million In Series A Financing 38 Proteon Therapeutics Secures US$15.2 Million In Venture Financing 39 OvaScience Secures US$6 Million In Series A Financing 41 Verastem Secures US$32 Million In Series B Financing 42 Verastem Secures US$16 Million In Series A Round Of Financing 44 Cerulean Pharma Secures US$24 Million In Series C Financing 46 Oxagen Raises US$33 Million In Series C Financing 48 7
Alnara Pharma Raises US$35 Million In Series B Financing 51 Biogen Idec Completes Acquisition Of Remaining Stake In Stromedix, Provider Of Therapies For Fibrosis 53 Insmed Acquires Transave 56 Eli Lilly Acquires Alnara Pharma 59 Bessemer Venture Partners, Key Competitors 61 Bessemer Venture Partners, Key Employees 62 Bessemer Venture Partners, Other Locations 63 8
List Of Figures, Charts and Diagrams in Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Bessemer Venture Partners, Medical Devices Deals, 2010 to YTD 2016 10 9
How to Buy... Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 10